Linda D. Shortliffe

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

Keith Syson Chan, Íñigo Espinosa, Mark P. Chao et al. · Proceedings of the National Academy of Sciences · 2009 · 673 citations · Full text

Clinical Prognosis, Cancer Biology, Molecular Heterogeneity +16

Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.

W G Harker, Fredrick J. Meyers, Fuad S. Freiha et al. · Journal of Clinical Oncology · 1985 · 353 citations

Urology, Genitourinary Cancer, Urinary Tract +10

Reaffirmation of AAP Clinical Practice Guideline: The Diagnosis and Management of the Initial Urinary Tract Infection in Febrile Infants and Young Children 2–24 Months of Age

Kenneth B. Roberts, Stephen M. Downs, S. Maria E. Finnell et al. · PEDIATRICS · 2016 · 318 citations

Clean Catheter, Antimicrobial Stewardship, Pediatric Epidemiology +20

Three differentiation states risk-stratify bladder cancer into distinct subtypes

Jens-Peter Volkmer, Debashis Sahoo, Robert Chin et al. · Proceedings of the National Academy of Sciences · 2012 · 261 citations · Full text

Tumor Biology, Urology, Engineering +14

Gpr124 is essential for blood–brain barrier integrity in central nervous system disease

Junlei Chang, Michael R. Mancuso, Carolina M. Maier et al. · Nature Medicine · 2017 · 251 citations · Full text

Neurodegenerative Diseases, Molecular Neuroscience, Neurobiology Of Disease +14